| | ACR Appropriateness Criteria® on Developmental Dysplasia of the Hip—ChildDevelopmental dysplasia of the hip (DDH) affects 1.5 of every 1,000 caucasian Americans and less frequently affects African Americans. Developmental dysplasia of the hip comprises a spectrum of abnormalities, ranging from laxity of the joint and mild subluxation to fixed dislocation. Early diagnosis of DDH usually leads to low-risk treatment with a harness. Late diagnosis of DDH in children may lead to increased surgical intervention and complications. Late diagnosis of DDH in adults can result in debilitating end-stage degenerative hip joint disease. Screening decreases the incidence of late diagnosis of DDH. Clinical evaluation for DDH should be performed periodically at each well-baby visit until the age of 12 months. There is no consensus on imaging screening for DDH. Consideration for screening with ultrasound is balanced between the benefits of early detection of DDH and the increased treatment and cost factors. In addition, randomized trials evaluating primary ultrasound screening did not find significant decrease in late diagnosis of DDH. In the United States, hip ultrasound is selectively performed in infants with risk factors, such as family history of DDH, breech presentation, and inconclusive findings on physical examination. Ultrasound for DDH should be performed after 2 weeks of age because laxity is common after birth and often resolves itself. A pelvic radiograph can optimally be performed after the age of 4 months, when most infants will have ossification centers of the femoral heads. Summary of Literature Review  Definition Developmental dysplasia of the hip (DDH), formerly known as congenital dislocation of the hip, comprises a spectrum of abnormalities, including abnormal acetabular shape (dysplasia) and malposition of the femoral head, ranging from dislocatable hip and mild subluxation to fixed dislocation. Incidence Developmental dysplasia of the hip affects 1.5 in 1,000 of the American caucasian population; it less frequently affects African Americans. It is 4 to 8 times more common in female individuals. It is also more common in patients with family histories of DDH, firstborns, large infants, and infants with histories of oligohydramnios. It is 3 times more common in the left hip than the right, likely because of the normal left occiput anterior position in utero, which places the left hip against the mother's spine and limits its abduction. Etiology The origin and pathogenesis of DDH are probably multifactorial. Abnormal laxity of the ligaments and hip capsule is seen in patients and families with DDH. The maternal hormone relaxin may also be a factor. Mechanical factors of reduced in utero space and movement restriction are thought to be causative in conditions such as oligohydramnios and being first born. Extreme hip flexion with knee extension, as in breech position, tends to promote femoral head dislocation and leads to shortening and contracture of the iliopsoas muscle. Natural History The natural history of DDH depends on the type and degree of hip abnormality. Mild dysplasia may never manifest clinically or become apparent until adult life, whereas severe dysplasia is most likely to present clinically during childhood. Most DDH identified during the newborn period represents hip laxity and immaturity. Sixty percent to 80% of abnormalities identified on physical examination and >90% identified on ultrasound resolve spontaneously [1, 2, 3, 4, 5]. Untreated subluxed and dislocated hips can lead to early degenerative joint disease and impaired function. Clinical Evaluation The clinical evaluation of the hips for DDH should be performed at each well-baby visit. The American Academy of Pediatrics recommends well-baby visits at 1 to 2 weeks and at 2, 4, 6, 9, and 12 months of age. As part of the clinical evaluation, it is important to elicit risk factors for DDH. Examination findings suggesting DDH include positive Ortolani or Barlow test results, asymmetric skin folds, and shortening of the thigh observed on the dislocated side. The Ortolani test consists of abducting and gently lifting the flexed thigh and pushing the greater trochanter anteriorly; this test is designed to enable the already dislocated hip to be detected by causing the femoral head to slip into the acetabulum; a “clunk” should be felt or heard. The second test, introduced by Barlow, consists of a gentle maneuver, with the thumb of one hand placed over the femoral neck and the fingers placed over the greater trochanter to try to 1) gently adduct the thigh and dislocate the femoral head posteriorly and then 2) gently lift the thigh upward while abducting the leg with the fingers over the greater trochanter, endeavoring to relocate the femoral head in its socket. The Barlow test aims to elicit a dislocation followed by reduction and identifies unstable hips missed by the Ortolani test. Both tests are designed to detect instability between the femoral head and acetabulum, indicating ligamentous or capsular laxity. In children aged >3 months, these tests are less likely to have positive results. In children aged >3 months, limitation of hip abduction and asymmetric thigh folds secondary to shortening are more useful clinical signs of DDH. Once a child is walking, there is a typical limp, and the child often toe-walks on the affected side. If both hips are dislocated, increased lumbar lordosis, prominent buttocks, and a waddling gait pattern are present. The physical examination may reveal a stable “clicking” hip, that is, a hip with no laxity but with a “click” elicited on the physical examination. The sensitivity and specificity of the clinical examination depend on the expertise of the evaluator. The effectiveness of clinical screening varies, depending on whether an orthopedic surgeon, experienced pediatrician, or intern performs the examination [6, 7, 8]. Radiographic Evaluation In the first month of life, when the femoral heads are composed entirely of cartilage, radiographs are of limited value unless a dislocation is present. Instability may be undetectable, and evaluation of acetabular development is influenced by the infant's position at the time the x-ray is taken. By 4 to 6 months of age, radiographs become more reliable (see Variant 4). They are readily available and relatively low in cost. Radiographs may be performed on patients with neuromuscular disorders, myelodysplasia, or arthrogryposis (teratologic dislocation) to assess other bony abnormalities. Radiography of the pelvis should be obtained with the hips in the neutral position. The von Rosen view, with the legs at a 45° angle, abduction, and the thighs internally rotated, may be helpful in accentuating a dislocated hip that may not be apparent on routine views. The frog-leg view may be obtained to assess reduction when the neutral view is abnormal. Dislocation or subluxation of the femoral head can be recognized by evaluating the relationship of the ossific nucleus of the femoral head and metaphysis to the acetabulum. The nucleus of the femoral head ossifies at approximately 4 months (50th percentile), with a normal range of 2 to 8 months [9]. The ossified femoral head nucleus allows easy evaluation of the relationship of the femoral head to the acetabulum. However, if the nucleus of the femoral head is not ossified, its position can be estimated. In addition to evaluating the relationship of the ossific nucleus of the femoral head, the relationship of the proximal femoral metaphysis to the acetabulum must also be evaluated [10]. As a child grows, adaptive changes of the hip joint and femur become more evident on routine radiography. In DDH, the roof of the acetabulum is vertically oriented, and often there is a delay in the appearance and growth of the ossific nucleus of the femoral head, compared to the normal hip. The radiographic evaluation consists predominantly of a visual assessment; however, measurement of the acetabular index is an objective parameter that may be used in the diagnosis and follow-up of patients with DDH. The 95% tolerance interval for intraobserver variability is 8.35°, with interobserver variability exceeding intraobserver variability; this measurement error casts doubt on the reliability of the acetabular index based on a single reading [11, 12]. Ultrasound Evaluation A high-frequency linear array transducer should be used for ultrasound evaluation of the hip. Two methods have emerged: an acetabular morphology method proposed by Graf [13] and a dynamic stress technique. In 1980, Graf [13] described a method of static ultrasound imaging in the coronal plane. In normal hips, the round, hypoechoic, speckled femoral head lies centered in the acetabulum. The Graf method is based on a single coronal image. The position of the femoral head, appearance of the bony acetabulum, and configuration of the cartilaginous acetabular rim, position of the cartilaginous labrum, and shape and echogenicity of the cartilaginous roof are all assessed, and the hip is assessed visually. An important adjunct in the evaluation of the hips by this method is the α angle. This angle is obtained by drawing a line along the lateral aspect of the ilium and another line from the lower iliac margin in the acetabular fossa to the lateral edge of the bony acetabular roof [14, 15]. Graf [13] developed a morphologic and geometric hip classification scheme (types I to IV) using an α angle, which measures the osseous acetabular roof angle, and a β angle, which defines the position of the echogenic fibrocartilaginous acetabular labrum. The hips are categorized according to the following classification: •Type I hips are normal and require no treatment and no follow-up; the α angle is >60°. •Type II hips are further subdivided into subtypes IIa, IIb, IIc, and IId. In subtype IIa, seen in infants aged <3 months of age, the hip is normally located, but the bony acetabulum is immature (the α angle is between 50° and 59°). These patients require no treatment, but there is a small risk for delayed displacement or acetabular dysplasia in this group, so follow-up is advised. Subtype IIb, IIc, and IId hips all require referral for treatment. •Type III hips (low displacement) and type IV hips (high displacement) are usually very apparent clinically, and both require immediate treatment. The α angle should be <43°. Interobserver variability of subjective evaluation and of acetabular angle measurements [16, 17, 18, 19] raises concerns about the operator dependence of ultrasound evaluation for DDH and may explain the variability of ultrasound screening positive rates found in the literature. Harcke and Grissom [20] and others developed the dynamic or real-time method, which attempts to visualize the Barlow and Ortolani maneuvers on ultrasound. This technique is performed in both the coronal and transverse planes, with and without stress. The modified Barlow maneuver is performed by holding the knee with the hip flexed 90° and in adduction. The femur is pushed (pistoned) posteriorly. In 1993, at a meeting at the Alfred I. DuPont Institute in Wilmington, Delaware, a North American standard for hip ultrasound was agreed upon, which combines the two techniques. The standard consists of 1) a coronal view in the Graf format and 2) a transverse view with the hip flexed, with and without modified Barlow stress maneuver [14]. Other Imaging Modalities Computed tomography and magnetic resonance imaging may be used to evaluate DDH in patients in casts after surgery or attempted closed reduction to confirm that the hip has been successfully reduced, late presentations, complex hip dislocations, or avascular necrosis. The primary use of computed tomography in DDH is for follow-up purposes rather than for initial diagnosis. Magnetic resonance imaging may be used in complex dislocations and suspected avascular necrosis. Arthrography is used primarily in the operating room by the orthopedic surgeon to evaluate lateral displacement of the femoral head and congruity after closed reduction of the hip and to assess for labral infolding that might prevent proper reduction. Timing of Evaluation The goal of a screening program is to detect all patients with DDH early on, when therapy is most effective and noninvasive, and to eliminate those patients without DDH in whom unnecessary treatment may be costly and harmful. Delayed diagnosis increases the risk for complications, and infants diagnosed after 6 months of age often require surgical correction. Two types of screening can be performed: generalized screening, in which all neonates are evaluated, and selective screening, in which only those at high risk are evaluated. Generalized Screening Clinical Evaluation Currently, every neonate undergoes a routine physical examination that includes evaluation of the hips for stability. Despite neonatal physical examination screening programs, late presentation of DDH has not been eliminated. The incidence of late diagnosis with screening remains within the same range as that of late diagnosis without screening, albeit at the lower margin [21]. However, it seems beyond debate that these clinical tests for dislocation and dislocatability are far from accurate in identifying future cases of unequivocal dislocation of the hip. Radiographic Evaluation There is no established role for the use of radiographs for generalized screening for DDH. Ultrasound Evaluation Despite some authors' results, the routine use of ultrasound in screening all neonates and infants cannot be recommended [21, 22, 23, 24]. The major objectives of adding ultrasound to the evaluation of patients with DDH are to reduce the incidence of late diagnosis and to reduce the number of normal hips being treated. Two randomized trials have addressed primary ultrasound screening. Compared with clinical evaluation, ultrasound more frequently detects DDH at an early stage and decreases the number of surgical interventions. Both studies found no significant difference in the rates of detection of late DDH in infants screened with ultrasound compared with those screened with high-quality serial physical examinations [25, 26]. However, both studies did find higher rates of abduction splinting and follow-up in the clinical evaluation group. This finding is also supported by systematic reviews of prior studies [21, 22, 23, 24, 27]. Some of these infants may be overdiagnosed [21, 22, 23, 24, 27]. The long-term outcomes of those who are treated for disorders they do not have are an important consideration because iatrogenic avascular necrosis of the femoral head may affect treated children and, in its severest forms, may lead to premature osteoarthritis [21, 23]. Selective Screening Clinical Evaluation All infants should be evaluated by physical examination at well-baby visits during the first year of life. Normal results on physical examination do not preclude the development of a dysplastic hip in an infant [3, 8]. Therefore, imaging (by radiography or ultrasound) should be performed despite normal results on physical examination in all infants at risk. Because instability often resolves spontaneously by 2 weeks of age, evaluation for instability should not take place before then. Radiographic Evaluation By 6 weeks of age, radiographic changes in the acetabulum and lateral displacement of the femoral neck and metaphysis can be recognized [28]. A radiographic screening program can be successfully implemented for infants at 4 months of age who were clinically normal at the neonatal examination but are considered to be at risk for DDH [29]. Ultrasound Evaluation Risk factors for DDH include breech presentation and positive family history. The American Academy of Pediatrics recommends hip imaging for female infants born in the breech position and optional hip imaging for male infants born in the breech position or for female infants with positive family histories of DDH [22, 24]. Selective ultrasound screening can identify DDH in children at high risk for DDH and negative physical examination findings [30, 31]. However, selective ultrasound screening has not been shown to significantly reduce diagnosis of late DDH [2, 30, 32, 33, 34]. In a 10-year prospective study of 34,723 British infants, 2,578 with clinical instability or risk factors were imaged with ultrasound. Instability was present in 77, of whom only 31% had risk factors. The authors concluded that selective ultrasound examination may be justified for infants with clinical instability, family histories of DDH, breech presentation, or postural foot deformities [35]. In an Irish study of 52,893 infants, ultrasound examination was performed on 5,485 infants who had first-degree relatives with DDH, breech presentation, or a persistent click in an otherwise stable hip. Eighteen (0.33%) were found to have dislocated hips, and 153 (2.78%) were found to have dysplastic hips. On the basis of the finding that 3.2 of 1,000 infants required treatment, the authors concluded that ultrasound screening in infants with such risk factors is worthwhile [30]. The value of selected ultrasound screening in infants with positive physical examinations was addressed in a 33-center study by the United Kingdom Hip Trial [36]. The study found that the use of ultrasound examinations in infants with clinically detected hip instability allowed a reduction in abduction splinting and was not associated with an increase in abnormal hip development or higher rates of surgical treatment [36]. This policy was found to reduce costs [37] (Variant 1). Treatment It is widely assumed that early treatment results in improved outcome. Although there is agreement in the literature that patients with dislocation should be treated and that those with stable “clicking” hips should be followed clinically, there is some disagreement regarding the treatment of patients with unstable (lax, but not displaced) hips. Some advocate early treatment for every patient with instability [38]. Others prefer clinical observation [39] because a significant number of these patients (80%) progress spontaneously to clinically normal status [40]. Relative Radiation Level Information  Potential adverse health effects associated with radiation exposure are an important factor to consider when selecting the appropriate imaging procedure. Because there is a wide range of radiation exposures associated with different diagnostic procedures, a relative radiation level indication has been included for each imaging examination. The relative radiation levels are based on effective dose, which is a radiation dose quantity that is used to estimate population total radiation risk associated with an imaging procedure (Table 1). Additional information regarding radiation dose assessment for imaging examinations can be found in ACR Appropriateness Criteria®: Radiation Dose Assessment Introduction [41]. Disclaimer: The ACR Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for the diagnosis and treatment of specified medical conditions. These criteria are intended to guide radiologists, radiation oncologists, and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient's clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those examinations generally used for the evaluation of a patient's condition are ranked. Other imaging studies necessary to evaluate other coexistent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the US Food and Drug Administration have not been considered in developing these criteria, but the study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination. References  1. 1Castelein RM, Sauter AJ. Ultrasound screening for congenital dysplasia of the hip in newborns: its value. J Pediatr Orthop. 1988;8:666–670. MEDLINE 2. 2Clarke NM, Clegg J, Al-Chalabi AN. Ultrasound screening of hips at risk for CDH (Failure to reduce the incidence of late cases). J Bone Joint Surg Br. 1989;71:9–12. 3. 3Gardiner HM, Dunn PM. Controlled trial of immediate splinting versus ultrasonographic surveillance in congenitally dislocatable hips. Lancet. 1990;336:1553–1556. Abstract |
CrossRef
4. 4Marks DS, Clegg J, al-Chalabi AN. Routine ultrasound screening for neonatal hip instability (Can it abolish late-presenting congenital dislocation of the hip?). J Bone Joint Surg Br. 1994;76:534–538. 5. 5Terjesen T, Holen KJ, Tegnander A. Hip abnormalities detected by ultrasound in clinically normal newborn infants. J Bone Joint Surg Br. 1996;78:636–640. 6. 6Andersson JE, Funnemark PO. Neonatal hip instability: screening with anterior-dynamic ultrasound method. J Pediatr Orthop. 1995;15:322–324. MEDLINE 7. 7Place MJ, Parkin DM, Fritton JM. Effectiveness of neonatal screening for congenital dislocation of the hip. Lancet. 1978;2:249–250.
CrossRef
8. 8Poul J, Bajerova J, Sommernitz M, Straka M, Pokorny M, Wong FY. Early diagnosis of congenital dislocation of the hip. J Bone Joint Surg Br. 1992;74:695–700. 9. 9Garn SM, Rohmann CG, Silverman FN. Radiographic standards for postnatal ossification and tooth calcification. Med Radiogr Photogr. 1967;43:45–66. 10. 10Bertol P, Macnicol MF, Mitchell GP. Radiographic features of neonatal congenital dislocation of the hip. J Bone Joint Surg Br. 1982;64:176–179. 11. 11Kay RM, Watts HG, Dorey FJ. Variability in the assessment of acetabular index. J Pediatr Orthop. 1997;17:170–173. MEDLINE |
CrossRef
12. 12Spatz DK, Reiger M, Klaumann M, Miller F, Stanton RP, Lipton GE. Measurement of acetabular index intraobserver and interobserver variation. J Pediatr Orthop. 1997;17:174–175. MEDLINE 13. 13Graf R. The diagnosis of congenital hip-joint dislocation by the ultrasonic Combound treatment. Arch Orthop Trauma Surg. 1980;97:117–133. MEDLINE |
CrossRef
14. 14American College of Radiology. ACR practice guideline for the performance of the ultrasound examination for detection of developmental dysplasia of the hip. In: Practice guidelines and technical standards. Reston, Va: American College of Radiology; 2007;p. 997–1001. 15. 15Graf R. Guide to sonography of the infant hip. New York: Thieme; 1987;. 16. 16Dias JJ, Thomas IH, Lamont AC, Mody BS, Thompson JR. The reliability of ultrasonographic assessment of neonatal hips. J Bone Joint Surg Br. 1993;75:479–482. 17. 17Engesaeter LB, Wilson DJ, Nag D, Benson MK. Ultrasound and congenital dislocation of the hip (The importance of dynamic assessment). J Bone Joint Surg Br. 1990;72:197–201. 18. 18Jomha NM, McIvor J, Sterling G. Ultrasonography in developmental hip dysplasia. J Pediatr Orthop. 1995;15:101–104. MEDLINE 19. 19Rosendahl K, Aslaksen A, Lie RT, Markestad T. Reliability of ultrasound in the early diagnosis of developmental dysplasia of the hip. Pediatr Radiol. 1995;25:219–224. MEDLINE |
CrossRef
20. 20Harcke HT, Grissom LE. Infant hip sonography: current concepts. Semin Ultrasound CT MR. 1994;15:256–263. Abstract |
Full-Text PDF (1165 KB)
|
CrossRef
21. 21Shipman SA, Helfand M, Moyer VA, Yawn BP. Screening for developmental dysplasia of the hip: a systematic literature review for the US Preventive Services Task Force. Pediatrics. 2006;117:e557–e576. 22. 22Committee on Quality Improvement, Subcommittee on Developmental Dysplasia of the Hip, American Academy of Pediatrics Clinical practice guideline: early detection of developmental dysplasia of the hip. Pediatrics. 2000;105:896–905. 23. 23Dezateux C, Rosendahl K. Developmental dysplasia of the hip. Lancet. 2007;369:1541–1552. Abstract | Full Text |
Full-Text PDF (211 KB)
|
CrossRef
24. 24Patel H. Preventive health care, 2001 update: screening and management of developmental dysplasia of the hip in newborns. CMAJ. 2001;164:1669–1677. MEDLINE 25. 25Holen KJ, Tegnander A, Bredland T, et al. Universal or selective screening of the neonatal hip using ultrasound? (A prospective, randomised trial of 15,529 newborn infants). J Bone Joint Surg Br. 2002;84:886–890.
CrossRef
26. 26Rosendahl K, Markestad T, Lie RT. Ultrasound screening for developmental dysplasia of the hip in the neonate: the effect on treatment rate and prevalence of late cases. Pediatrics. 1994;94:47–52. 27. 27Woolacott NF, Puhan MA, Steurer J, Kleijnen J. Ultrasonography in screening for developmental dysplasia of the hip in newborns: systematic review. BMJ. 2005;330:1413. 28. 28Hensinger RN. Treatment in early infancy: birth to two months. In: Tachdjian MO editors. Congenital dislocation of the hip. New York: Churchill Livingstone; 1982;p. 159–171. 29. 29Garvey M, Donoghue VB, Gorman WA, O'Brien N, Murphy JF. Radiographic screening at four months of infants at risk for congenital hip dislocation. J Bone Joint Surg Br. 1992;74:704–707. 30. 30Lowry CA, Donoghue VB, Murphy JF. Auditing hip ultrasound screening of infants at increased risk of developmental dysplasia of the hip. Arch Dis Child. 2005;90:579–581.
CrossRef
31. 31Tonnis D, Storch K, Ulbrich H. Results of newborn screening for CDH with and without sonography and correlation of risk factors. J Pediatr Orthop. 1990;10:145–152. MEDLINE 32. 32Boeree NR, Clarke NM. Ultrasound imaging and secondary screening for congenital dislocation of the hip. J Bone Joint Surg Br. 1994;76:525–533. 33. 33Teanby DN, Paton RW. Ultrasound screening for congenital dislocation of the hip: a limited targeted programme. J Pediatr Orthop. 1997;17:202–204. MEDLINE |
CrossRef
34. 34Roovers EA, Boere-Boonekamp MM, Mostert AK, Castelein RM, Zielhuis GA, Kerkhoff TH. The natural history of developmental dysplasia of the hip: sonographic findings in infants of 1-3 months of age. J Pediatr Orthop B. 2005;14:325–330. 35. 35Paton RW, Hinduja K, Thomas CD. The significance of at-risk factors in ultrasound surveillance of developmental dysplasia of the hip (A ten-year prospective study). J Bone Joint Surg Br. 2005;87:1264–1266.
CrossRef
36. 36Elbourne D, Dezateux C, Arthur R, et al. Ultrasonography in the diagnosis and management of developmental hip dysplasia (UK Hip Trial): clinical and economic results of a multicentre randomised controlled trial. Lancet. 2002;360:2009–2017. Abstract | Full Text |
Full-Text PDF (116 KB)
|
CrossRef
37. 37Gray A, Elbourne D, Dezateux C, King A, Quinn A, Gardner F. Economic evaluation of ultrasonography in the diagnosis and management of developmental hip dysplasia in the United Kingdom and Ireland. J Bone Joint Surg Am. 2005;87:2472–2479. MEDLINE 38. 38Dunn PM, Evans RE, Thearle MJ, Griffiths HE, Witherow PJ. Congenital dislocation of the hip: early and late diagnosis and management compared. Arch Dis Child. 1985;60:407–414.
CrossRef
39. 39Burger BJ, Burger JD, Bos CF, Obermann WR, Rozing PM, Vandenbroucke JP. Neonatal screening and staggered early treatment for congenital dislocation or dysplasia of the hip. Lancet. 1990;336:1549–1553. Abstract |
CrossRef
40. 40Gardiner HM, Duncan AW. Radiological assessment of the effects of splinting on early hip development: results from a randomised controlled trial of abduction splinting vs sonographic surveillance. Pediatr Radiol. 1992;22:159–162. MEDLINE |
CrossRef
41. 41American College of Radiology. ACR Appropriateness Criteria®: radiation dose assessment introduction. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/app_criteria/RRLInformation.aspx. a Riley Hospital for Children, Indiana University, Indianapolis, Indiana b Columbus Children's Hospital, Columbus, Ohio c The Children's Hospital, Denver, Colorado d Children's National Medical Center, Washington, DC e University of North Carolina, Chapel Hill, North Carolina f Wilford Hall Medical Center, Lackland Air Force Base, Texas g Primary Children's Medical Center, Salt Lake City, Utah h Tampa General Hospital, Tampa, Florida i American Pediatric Surgical Association, Deerfield, Illinois j The Office of Pediatric Therapeutics in the Office of the Commissioner, US Food and Drug Administration, Rockville, Maryland k American Academy of Pediatrics, Elk Grove Village, Illinois Corresponding author and reprints: Boaz K. Karmazyn, MD, Riley Hospital for Children, Indiana University, 702 Barnhill Drive, Room 1053, Indianapolis, IN 46202-5200
The views expressed are those of the authors and do not necessarily reflect or represent endorsement by the Food and Drug Administration. The American College of Radiology seeks and encourages collaboration with other organizations on the development of the ACR Appropriateness Criteria® through society representation on expert panels. Participation by representatives from collaborating societies on the expert panel does not necessarily imply society endorsement of the final document. PII: S1546-1440(09)00189-6 doi:10.1016/j.jacr.2009.04.008 © 2009 American College of Radiology. Published by Elsevier Inc. All rights reserved. | |
|